The estimated Net Worth of Susan Richards Windham Bann... is at least $5 dollars as of 4 May 2023. Susan Bann owns over 5,000 units of Aridis Pharmaceuticals Inc stock worth over $5 and over the last 6 years Susan sold ARDS stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Susan Bann ARDS stock SEC Form 4 insiders trading
Susan has made over 1 trades of the Aridis Pharmaceuticals Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Susan exercised 5,000 units of ARDS stock worth $5 on 4 May 2023.
The largest trade Susan's ever made was exercising 5,000 units of Aridis Pharmaceuticals Inc stock on 4 May 2023 worth over $5. On average, Susan trades about 714 units every 0 days since 2018. As of 4 May 2023 Susan still owns at least 5,000 units of Aridis Pharmaceuticals Inc stock.
You can see the complete history of Susan Bann stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Susan Bann's mailing address?
Susan's mailing address filed with the SEC is 78 Blanchard Rd, Burlington, MA 01803, USA.
Insiders trading at Aridis Pharmaceuticals Inc
Over the last 6 years, insiders at Aridis Pharmaceuticals Inc have traded over $0 worth of Aridis Pharmaceuticals Inc stock and bought 1,445,847 units worth $181,502 . The most active insiders traders include Vu Truong, Eric Patzer a Fred Kurland. On average, Aridis Pharmaceuticals Inc executives and independent directors trade stock every 89 days with the average trade being worth of $125. The most recent stock trade was executed by Eric Patzer on 24 June 2024, trading 714,286 units of ARDS stock currently worth $50,000.
What does Aridis Pharmaceuticals Inc do?
aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.
What does Aridis Pharmaceuticals Inc's logo look like?
Complete history of Susan Bann stock trades at Cambridge Bancorp a Aridis Pharmaceuticals Inc
Aridis Pharmaceuticals Inc executives and stock owners
Aridis Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Dr. Vu L. Truong,
Founder, CEO & Director -
Fred Kurland,
Consultant -
Fred Kurland J.D., M.B.A.,
Chief Financial Officer -
Dr. Hasan Jafri M.D.,
Chief Medical Officer -
Jeffrey J. Fessler Esq., J.D.,
Acting Gen. Counsel -
Michael A. Nazak,
Chief Financial Officer -
Dr. Eric J. Patzer,
Exec. Chairman -
Vu Truong,
CEO -
Wolfgang Dummer,
Chief Medical Officer -
Robert R Ruffolo,
Director -
Craig S Gibbs,
Director -
John F Hamilton,
Director -
Susan Richards Windham Bann...,
Director -
Hasan Jafri,
Chief Medical Officer -
Fred Kurland,
CFO -
Eric Patzer,
Director